DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy
Photo: HealthVetted editorial render
GLP-1 receptor agonist

Photo: HealthVetted editorial render
GLP-1 receptor agonist
| # | Product | Active ingredient | Starting price | FDA status | Score | |
|---|---|---|---|---|---|---|
| 1 | Online-Therapy.com | — | Best ·$50/mo | service | Top ·7.6 | See offer → |
| 2 | Cerebral | — | $85/mo | service | 6.8 | See offer → |
Online-Therapy.com is a delivery platform built around cognitive behavioral therapy (CBT), one of the most evidence-based talk-therapy models. After you pick your areas of concern and get matched with a licensed therapist, you work through an eight-section online CBT course delivered as video, audio, and text. The program's "toolbox" reinforces the work: interactive worksheets your therapist reviews and responds to (per the company, replies come on weekdays, typically within about 24 hours), a daily journal, an activity-planning tool, progress tests, and yoga/meditation videos. You also get unlimited asynchronous messaging with your therapist, and depending on your plan, one or two 45-minute live sessions per week by video, voice, or text chat. The goal is to help you identify and reframe unhelpful thoughts and behaviors through continuous practice between sessions. The therapy itself is standard CBT, just delivered remotely.
Cerebral is not a drug or device; it is a telehealth service that connects you to licensed providers online. After a brief intake assessment, you are matched with a therapist for video or phone sessions using evidence-based methods such as cognitive behavioral therapy (CBT), and/or a prescriber who can evaluate you and prescribe non-controlled psychiatric medications (commonly SSRIs and SNRIs) for conditions like depression and anxiety. The platform handles scheduling, secure messaging, and medication coordination, with prescriptions sent to your pharmacy or shipped. The therapeutic benefit comes from the underlying treatments and the provider relationship, not the app itself.
Online-Therapy.com has not published independent peer-reviewed trials of its own program, so its efficacy case rests on the broad evidence base for guided internet-delivered CBT (iCBT), which closely mirrors its model rather than proving results for this specific platform. A 2020 systematic review and meta-analysis in the Journal of Medical Internet Research found large effects for iCBT in routine care: Hedges' g = 1.18 (95% CI 1.06-1.29) for depression and g = 0.94 (95% CI 0.83-1.06) for anxiety, with outcomes broadly comparable to face-to-face therapy and larger effects on depression when trained professionals provided the guidance (g = 1.27 vs 0.92; this professional advantage was not seen for anxiety). Deterioration rates were low (about 2.5 percent for depression and 3.1 percent for anxiety). These are category-level findings, not measurements of Online-Therapy.com. Reviewer-conducted user surveys (for example, HelpGuide's survey of 100 users) reported roughly 87 percent overall satisfaction, but satisfaction surveys are not clinical outcome measures and should be read as user sentiment, not proof of effectiveness.
There are no clinical trials of Cerebral the company; the relevant evidence is for the treatments it delivers. A 2022 meta-analysis of randomized controlled trials (Giovanetti et al., Telemedicine and e-Health) found video-based psychotherapy essentially equivalent to in-person therapy for depression (Hedges g of about 0.04, i.e., no meaningful difference), with comparable dropout rates. For medication, Cipriani et al.'s 2018 Lancet network meta-analysis of 21 antidepressants found every drug studied was more effective than placebo for acute major depression, with response odds ratios ranging from about 1.37 to 2.13; the broader literature puts the average antidepressant-versus-placebo effect in the modest range (standardized mean difference roughly 0.30). So the modalities Cerebral uses are well supported, while the size of the benefit is moderate and quality depends heavily on your individual provider.
As talk therapy, Online-Therapy.com has no pharmacological side effects. The most common downside is temporary emotional discomfort when working through difficult thoughts or memories, which is a normal part of CBT. Research on guided iCBT shows low symptom-deterioration rates (roughly 2.5-3 percent), but a minority of people do not improve or feel worse, especially if the modality or therapist fit is poor. Because the platform cannot prescribe medication or provide real-time crisis intervention, the main risk is relying on it for conditions it is not designed to treat. Anyone experiencing worsening symptoms, suicidal thoughts, or a crisis should seek in-person or emergency care immediately and contact 988 or 911.
Therapy itself carries little physical risk, though some people feel temporary emotional discomfort discussing difficult topics. The main medical risks come from any prescribed medication. SSRIs and SNRIs commonly cause nausea, headache, insomnia or drowsiness, sexual dysfunction, and weight changes. Serious but less common risks include serotonin syndrome, and antidepressants carry an FDA boxed warning for increased suicidal thoughts and behavior in people under 25, especially early in treatment or after dose changes. Never stop an antidepressant abruptly, as this can cause withdrawal symptoms. Report worsening mood, agitation, or suicidal thoughts to your prescriber immediately, and call or text 988 in a crisis.
As of 2026, Online-Therapy.com is self-pay with three individual tiers billed monthly: Basic about $60/week (roughly $260/month), Standard about $90/week (roughly $390/month), and Premium about $120/week (roughly $520/month); a Couples plan is also offered. New users typically get 20 percent off the first month. It does not accept insurance and is not in-network, but it does accept HSA/FSA cards (your card issuer can still approve or decline the charge), and it provides itemized receipts you can submit to your insurer to seek possible out-of-network reimbursement. Pricing can change with promotions, so confirm current rates at checkout.
As of 2026, out-of-pocket prices are roughly $175 per therapy session (with discounted bundles such as about $795 for three months of regular sessions), around $60 per month for medication management (billed about $180 per quarter, with the medication itself extra), roughly $365 per month for combined medication plus therapy, and about $325 per month for couples therapy; veterans may receive a discount. With in-network insurance (Cerebral lists partners such as Aetna, Blue Cross Blue Shield, Cigna, Optum, and UnitedHealthcare), copays average around $30 per session. Prices change frequently, so confirm current rates, your coverage, and your exact copay before starting, since some users have reported surprise charges.
Best for adults (18+) with mild-to-moderate anxiety, depression, stress, low self-esteem, or relationship issues who are self-motivated and comfortable with a homework-driven CBT format and a digital-first relationship with their therapist. A separate Couples plan exists. It is the wrong choice if you need psychiatric medication (the platform does not prescribe), have a severe or unstable condition, experience active suicidal thoughts, psychosis, mania, or substance-use emergencies, or want to bill in-network insurance. Minors and anyone in crisis should not use it. In an emergency, call 911 or call or text the 988 Suicide and Crisis Lifeline.
Cerebral is designed for US adults 18 and older seeking online therapy or medication management for conditions such as depression, anxiety, insomnia, and bipolar disorder; teen therapy is available in a limited set of states. It is a poor fit for anyone needing controlled substances, including stimulants for ADHD (Adderall, Vyvanse, Ritalin) or benzodiazepines (Xanax), which Cerebral stopped prescribing for most patients in 2022. It is not appropriate for psychiatric emergencies, active suicidal crisis, psychosis, or severe conditions requiring in-person or higher-level care. Anyone in crisis should call or text 988 or go to an emergency room.
Cerebral: Cerebral is a subscription telehealth platform offering online therapy and psychiatric medication management for depression, anxiety, and related conditions across all 50 states. The teletherapy and antidepressants it delivers are evidence-backed treatments. But a history of DOJ and FTC settlements over controlled-substance prescribing, data sharing, and billing means you should watch the subscription terms closely. On balance, Online-Therapy.com edges ahead in our scoring, but the right choice depends on your situation.
Editorial comparison, not medical advice. Discuss options with a qualified clinician. Individual results vary.